NEWS DETAIL

CodeBreaK 101 à l’ASCO 2025 : Triplet de Sotorasib dans KRAS CRC – Oncodaily

CodeBreaK 101 à l'ASCO 2025 : Trithérapie par sotorasib pour le cancer colorectal KRAS (Oncodaily)

Informations médicales July 2, 2026

Contenu integral de l article

ASCO 2025: CodeBreaK 101 shows sotorasib triplet therapy offers durable responses in KRAS G12C-mutant metastatic colorectal cancer. , ASCO 2025 Annual Meeting, CodeBreaK 101 trial, colorectal cancer, KRASG12C

Produits lies a cet article

Ces produits ont ete automatiquement associes au titre, au resume et au contenu de l article.

Questions frequentes

Which products are related to this article?

The system matched these relevant products from the article content: Lucius Sotorasib – Acheter en ligne SOTOLDX Sotorasib 120 mg.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.